Open Access627. CURE ID as a Tool for Curating and Analyzing Drugs Used in COVID-19 Clinical Trials
Author(s) -
Reema Charles,
Parvesh Paul,
Heather Stone,
Serghei Gorobet,
Belinda Nhundu,
Katarzyna M Borkowski,
Mili Duggal,
Raghavendra Tirupathi
Publication year - 2021
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofab466.825
Subject(s) - medicine , clinical trial , repurposing , azithromycin , hydroxychloroquine , tocilizumab , phases of clinical research , covid-19 , infectious disease (medical specialty) , disease , ecology , microbiology and biotechnology , biology , antibiotics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom